(NASDAQ: BRKR) Bruker's forecast annual revenue growth rate of 3.67% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.8%.
Bruker's revenue in 2025 is $3,446,100,000.On average, 5 Wall Street analysts forecast BRKR's revenue for 2025 to be $531,772,071,586, with the lowest BRKR revenue forecast at $526,980,635,975, and the highest BRKR revenue forecast at $533,770,776,068. On average, 5 Wall Street analysts forecast BRKR's revenue for 2026 to be $558,653,813,438, with the lowest BRKR revenue forecast at $553,030,468,229, and the highest BRKR revenue forecast at $567,289,610,891.
In 2027, BRKR is forecast to generate $594,081,948,980 in revenue, with the lowest revenue forecast at $591,919,590,151 and the highest revenue forecast at $596,185,210,405.